[Thrombosis of the cerebral veins and sinuses in 62 patients]

Ned Tijdschr Geneeskd. 1995 Jun 24;139(25):1286-91.
[Article in Dutch]

Abstract

Objective: Analysis of signs, symptoms, course and treatment of patients with cerebral venous and sinus thrombosis (CVST).

Design: Retrospective study.

Setting: Neurological departments of Dutch teaching hospitals.

Method: Analysis of data of patients admitted to the neurological wards of nine teaching hospitals, diagnosed from 1970 to 1990. All patients with a clinical diagnosis of CVST, confirmed by X-ray angiography, magnetic resonance imaging, surgery or autopsy were included. Patients with cavernous sinus thrombosis were excluded. The clinical condition of patients after 3 months was scored on a 4-point scale.

Results: Of 93 patients 62 fulfilled the inclusion criteria. Three months after the diagnosis 41 patients (66%) had recovered, 10 patients (16%) were seriously disabled, 11 patients (18%) had died. Factors associated with a poor outcome were coma (relative risk 3.5) and hemiparesis (relative risk 2.3) at the time of diagnosis. Signs of cerebral haemorrhage or infarction (by computed X-ray tomography) were associated with disability or death. Anticoagulant treatment was not significantly associated with a better or poorer outcome in these patients.

Conclusion: This study confirms the variations in causes, clinical presentation, natural history, and treatment of CVST. No conclusion could be drawn about the effect of anticoagulant treatment.

Publication types

  • Multicenter Study

MeSH terms

  • Anticoagulants / therapeutic use
  • Cerebral Angiography
  • Cerebral Veins*
  • Coma / complications
  • Hemiplegia / complications
  • Humans
  • Intracranial Embolism and Thrombosis / diagnosis*
  • Intracranial Embolism and Thrombosis / drug therapy
  • Magnetic Resonance Angiography
  • Magnetic Resonance Imaging
  • Outcome Assessment, Health Care
  • Retrospective Studies
  • Sinus Thrombosis, Intracranial / diagnosis*
  • Sinus Thrombosis, Intracranial / drug therapy

Substances

  • Anticoagulants